ABTZY yields 3.75% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, ABTZY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABTZY + JNJ for your $10,000?
Aboitiz Equity Ventures, Inc., a conglomerate, engages in the power, financial services, food manufacturing, real estate, and infrastructure businesses in the Philippines and internationally. It is involved in the power generation, distribution, and retail of electricity supply; provision of banking and financial services; production of feeds and flour, hog and layer farm, and animal nutrition products; and development of residential communities. The company also offers water and wastewater-related services to residential, commercial, and industrial customers; digital infrastructure services; operates regional airports; operates integrated economic estates projects; and manufactures and distributes cement. In addition, it provides aviation services; insurance products; and portfolio investment services. The company was formerly known as Cebu Pan Asian Holdings, Inc. and changed its name to Aboitiz Equity Ventures, Inc. in December 1993. Aboitiz Equity Ventures, Inc. was incorporated in 1989 and is headquartered in Taguig City, the Philippines.
Full ABTZY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.